ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Italy Fines Apple €98.6 Million Over App Store Dominance 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
MANHATTAN, N.Y., Sept. 12, 2017 -- Epica International, Inc., a leading robotic CT company based in San Clemente, California, recently announced the closing of a financing round with the investment group, Partners for Growth. PFG structured the $5 million term-debt facility in a key capital raise, providing growth capital to support Epica’s expansion into new markets across both imaging and robotics.
The NYC management consultancy, Facilitated Growth, acted as the key advisor on this deal, assisting in the rigorous diligence process for Epica’s five growing subsidiaries; a non-invasive CT medical imaging company, a robotics company, an advanced R&D technology center, a medical products distribution company, and a technical and scientific distribution group.
The funds are earmarked for use on growing operations, increasing the sales force, and preparing for entry into the human market. “This infusion of capital will assist us in furthering our goals to integrate CT imagery with precision robotics and ultimately deliver the future of medical diagnosis and therapy,” said Epica CEO, Frank D’Amelio.
Contact Info: Joe Soto, Facilitated Growth, [email protected], 212-697-1316
